Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Neuropace
NPCE
$439M
| $614K | ﹤0.01% |
81,200
-38,771
| -32% | -$391K |
|
2602
RadNet
RDNT
$5.02B
| $613K | ﹤0.01% |
10,400
-20,700
| -67% | -$1.12M |
|
2603
Merck
MRK
$322B
| $610K | ﹤0.01% |
4,915
-195,287
| -98% | -$25.2M |
|
2604
ImmuCell
ICCC
$101M
| $609K | ﹤0.01% |
125,589
+700
| +0.6% | +$3.37K |
|
|
SHCO
2605
DELISTED
Soho House & Co
SHCO
| $609K | ﹤0.01% |
114,702
+9,502
| +9% | +$50.9K |
|
2606
Toro Company
TTC
$8.75B
| $608K | ﹤0.01% |
+6,500
| New | +$573K |
|
|
SYRS
2607
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $606K | ﹤0.01% |
117,435
-2,400
| -2% | -$12.6K |
|
2608
Dimensional International Small Cap Value ETF
DISV
$4.95B
| $605K | ﹤0.01% |
22,500
+400
| +2% | +$11K |
|
2609
National Bankshares
NKSH
$259M
| $604K | ﹤0.01% |
21,370
+500
| +2% | +$14.8K |
|
2610
Tiptree Inc
TIPT
$662M
| $604K | ﹤0.01% |
36,600
-2,737
| -7% | -$45.8K |
|
2611
Coinshares Bitcoin ETF
BRRR
$396M
| $603K | ﹤0.01% |
+35,500
| New | +$660K |
|
2612
Idaho Strategic Resources
IDR
$444M
| $599K | ﹤0.01% |
60,750
+12,050
| +25% | +$112K |
|
|
TERN
2613
DELISTED
Terns Pharmaceuticals
TERN
| $596K | ﹤0.01% |
+87,500
| New | +$530K |
|
2614
Sprinklr
CXM
$1.49B
| $595K | ﹤0.01% |
61,800
-316,400
| -84% | -$3.54M |
|
2615
Vanguard Consumer Discretionary ETF
VCR
$6.15B
| $594K | ﹤0.01% |
1,901
-499
| -21% | -$153K |
|
2616
Oramed Pharmaceuticals
ORMP
$167M
| $593K | ﹤0.01% |
230,800
+108,700
| +89% | +$258K |
|
2617
Altisource Portfolio Solutions
ASPS
$63.6M
| $591K | ﹤0.01% |
52,403
-400
| -0.8% | -$5.56K |
|
2618
Data Storage Corp
DTST
$7.13M
| $590K | ﹤0.01% |
89,900
+39,900
| +80% | +$236K |
|
|
IAS
2619
DELISTED
Integral Ad Science
IAS
| $588K | ﹤0.01% |
60,500
-4,300
| -7% | -$41.2K |
|
2620
Farmers National Banc Corp
FMNB
$939M
| $586K | ﹤0.01% |
46,884
-7,100
| -13% | -$87.3K |
|
2621
iShares Global Healthcare ETF
IXJ
$4.07B
| $585K | ﹤0.01% |
6,300
-14,736
| -70% | -$1.34M |
|
2622
Hamilton Beach Brands
HBB
$311M
| $585K | ﹤0.01% |
34,007
+15,007
| +79% | +$305K |
|
2623
Citi Trends
CTRN
$555M
| $584K | ﹤0.01% |
+27,457
| New | +$630K |
|
2624
Schwab International Small-Cap Equity ETF
SCHC
$5.39B
| $584K | ﹤0.01% |
16,400
+10,700
| +188% | +$381K |
|
2625
Lineage Cell Therapeutics
LCTX
$269M
| $582K | ﹤0.01% |
583,622
+53,022
| +10% | +$58.6K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.